N-(2-methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine
- $126 - $752
- Product name: N-(2-methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine
- CAS: 1114597-69-1
- MF: C13H18N2O2
- MW: 234.29
- EINECS:
- MDL Number:MFCD11982917
- Synonyms:N-(2-methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine;2-methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethanamine;1H-Indole-3-methanamine, 5-methoxy-N-(2-methoxyethyl)-;2-Methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethan-1-amine
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM234246
- Product description2-Methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethanamine 95%+
- Packaging5g
- Price$711
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11351096
- Product description2-Methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethanamine 97%
- Packaging5g
- Price$752
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number036993
- Product descriptionN-(2-Methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine
- Packaging500mg
- Price$126
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number036993
- Product descriptionN-(2-Methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine
- Packaging1g
- Price$194
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM234246 | 2-Methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethanamine 95%+ | 5g | $711 | 2021-12-16 | Buy |
Crysdot | CD11351096 | 2-Methoxy-N-((5-methoxy-1H-indol-3-yl)methyl)ethanamine 97% | 5g | $752 | 2021-12-16 | Buy |
Matrix Scientific | 036993 | N-(2-Methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine | 500mg | $126 | 2021-12-16 | Buy |
Matrix Scientific | 036993 | N-(2-Methoxyethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine | 1g | $194 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|